For Doctors in a Hurry
- Researchers investigated how the timing and frequency of palliative care referrals influence end-of-life outcomes for patients with metastatic solid tumors.
- This retrospective study analyzed 779 patients at two cancer centers to identify factors associated with outpatient palliative care referral patterns.
- Early referral occurred in 38.9 percent of cases and increased hospice enrollment odds by 1.016 per month (p=0.01).
- The researchers concluded that the timing of referral significantly impacts end-of-life outcomes more than the total number of appointments.
- Clinicians should prioritize early referral to improve end-of-life care, supporting models that emphasize timing over high visit intensity.
Managing metastatic solid tumors requires a complex balance of systemic therapy, symptom control, and long-term planning to maintain quality of life [1, 2]. While clinical guidelines recommend early integration of supportive services, many patients still experience high symptom burdens and frequent acute care utilization near the end of life [3, 4]. Barriers such as socioeconomic status and varying disease trajectories often complicate the standardized delivery of these services [5, 6]. The optimal model for providing this care remains a subject of active clinical debate, as some investigations into nurse-led primary palliative care have shown no significant difference in quality of life or symptom burden compared to standard care [7]. Other evidence suggests that referral timing may be more influential than visit intensity for improving end-of-life outcomes and reducing intensive care unit utilization [8]. A recent retrospective analysis clarifies the factors driving these referral patterns and their direct impact on terminal care metrics, offering practical guidance for oncology clinics.
Disparities in Referral Patterns by Malignancy and Insurance
To evaluate how timing impacts end-of-life outcomes, researchers conducted a retrospective analysis of 779 patients with metastatic solid tumors referred to outpatient palliative care at two cancer center sites between 2021 and 2023. The authors defined early referral as a consultation occurring within three months of the initial diagnosis. Using bivariate analysis (a statistical method that compares two variables to determine their relationship), the data revealed that only 38.9% of patients received an early referral. This indicates that the majority of patients with metastatic disease navigate the critical first trimester of their diagnosis without specialized supportive care.
The timing of these referrals showed significant variation based on the specific type of malignancy (p < 0.001). Patients with head and neck cancer demonstrated the highest rate of early referral at 53.3%, likely reflecting the immediate and severe symptom burden associated with these tumors. In contrast, patients with breast cancer demonstrated the lowest rate of early referral at 9.6%. This discrepancy highlights a substantial gap in how palliative services are integrated across different oncological specialties, potentially driven by varying expected survival trajectories. Furthermore, socioeconomic factors emerged as a significant driver of referral patterns. Patients with Medicaid insurance were more likely to receive an early referral compared to those with other insurance types, with rates of 42.8% and 35.2%, respectively (p = 0.04). For practicing oncologists, these disparities underscore the need for standardized, symptom-triggered referral pathways that rely less on individual clinician habits or patient demographics.
Clinical Impact of Referral Timing on Terminal Care
Among the 321 patients who died during the follow-up period, the timing of the initial palliative care consultation proved to be a critical determinant of end-of-life care quality. Specifically, earlier referral relative to death was associated with increased hospice enrollment, demonstrating an odds ratio of 1.016 per month (p = 0.01). For every additional month of palliative involvement before death, the likelihood of transitioning to hospice care increased. This underscores the role of early supportive intervention in facilitating timely conversations about prognosis, allowing patients to transition from life-prolonging therapy to comfort-oriented care before a crisis occurs.
The timing of referral also significantly influenced the intensity of medical interventions in the final stages of life. Earlier referral relative to death was associated with reduced chemotherapy use at the end of life (odds ratio 0.964 per month, p = 0.002). Furthermore, researchers observed a marked reduction in high-intensity acute care. Earlier referral was associated with decreased utilization of the intensive care unit, yielding an incidence rate ratio (a statistical measure comparing the frequency of events between groups) of 0.962 (p = 0.02). These data indicate that early integration of palliative care helps patients avoid aggressive, potentially futile treatments and invasive monitoring during the terminal phase.
Beyond reducing aggressive interventions, the timing of the initial consultation directly impacted where patients spent their final days. Earlier referral was associated with lower rates of hospital death (odds ratio 0.988 per month, p = 0.04). This shift away from inpatient mortality suggests that early palliative involvement better supports the preference of many patients to die at home or in a dedicated hospice facility.
Prioritizing Early Access Over Visit Volume
To determine whether clinical benefits were driven by the duration of palliative involvement or the frequency of contact, the researchers compared the impact of referral timing against the total number of appointments. The data revealed that the timing of the initial referral was more influential than visit intensity across all measured end-of-life outcomes. While clinicians often assume that frequent follow-up is necessary to reduce acute care utilization, these findings suggest that establishing early palliative contact is the primary driver of improved terminal care metrics.
This distinction carries significant implications for resource management in busy oncology clinics, strongly supporting the implementation of stepped models of care. In a stepped model, the intensity of intervention is scaled up only if the patient does not respond to lower-intensity initial care, rather than providing high-frequency services to everyone from the outset. The study findings align perfectly with this framework, noting that stepped models have shown non-inferior outcomes compared to standard early palliative care despite requiring fewer visits. By prioritizing an early referral date over a high volume of subsequent visits, health systems can optimize critical end-of-life outcomes, including the observed reductions in intensive care unit utilization (incidence rate ratio 0.962, p = 0.02) and terminal chemotherapy (odds ratio 0.964 per month, p = 0.002). For practicing physicians, this means that simply introducing the palliative care team early in the metastatic disease course provides profound benefits, even if the patient only sees that team occasionally.
References
1. Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2022. doi:10.6004/jnccn.2022.0008
2. Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA A Cancer Journal for Clinicians. 2021. doi:10.3322/caac.21657
3. Snijders RAH, Brom L, Theunissen M, Everdingen MVDB. Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis. Cancers. 2023. doi:10.3390/cancers15030591
4. Kandarian B, Morrison RS, Richardson LD, Ortiz J, Grudzen CR. Emergency department-initiated palliative care for advanced cancer patients: protocol for a pilot randomized controlled trial.. Trials. 2014. doi:10.1186/1745-6215-15-251
5. Celis EPD, Guerra Y, Ramos-López W, et al. Randomized controlled trial (RCT) of a patient navigation (PN) intervention to increase early access to supportive care (SC) for patients with metastatic cancer in a resource-limited setting.. Journal of Clinical Oncology. 2019. doi:10.1200/JCO.2019.37.15_SUPPL.11505
6. Smith GL, López-Olivo MA, Advani P, et al. Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes. Journal of the National Comprehensive Cancer Network. 2019. doi:10.6004/jnccn.2019.7305
7. Schenker Y, Althouse AD, Rosenzweig M, et al. Effect of an Oncology Nurse-Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial.. JAMA internal medicine. 2021. doi:10.1001/jamainternmed.2021.5185
8. Crowley F, Sheng T, Zeng L, et al. Patterns of referral to embedded palliative care and impact of timing on end-of-life outcomes.. Journal of pain and symptom management. 2026. doi:10.1016/j.jpainsymman.2026.04.608
